サンプル依頼リスト カート
  • English
  • Korean
表紙：代謝性疾患治療薬の世界市場（2022年）
市場調査レポート
商品コード
1063051

代謝性疾患治療薬の世界市場（2022年）

Metabolic Disorders Drugs Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
代謝性疾患治療薬の世界市場（2022年）
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の代謝性疾患治療薬市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、戦略、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの構造

第3章 代謝性疾患治療薬市場の特徴

  • 市場の定義
  • 主要セグメンテーション

第4章 代謝性疾患治療薬市場の製品分析

  • 主な製品/サービス
  • 主な機能と差別化要因
  • 開発製品

第5章 代謝性疾患治療薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • エンドカスタマー

第6章 代謝性疾患治療薬市場の顧客情報

  • 顧客の選好
  • 最終用途の市場規模と成長

第7章 代謝性疾患治療薬市場の動向と戦略

第8章 代謝性疾患治療薬に対するCOVID-19の影響

第9章 代謝性疾患治療薬の市場規模と成長

  • 市場規模
  • 市場成長実績（金額）
    • 市場促進要因
    • 市場抑制要因
  • 市場成長予測（金額）
    • 市場促進要因
    • 市場抑制要因

第10章 代謝性疾患治療薬市場の地域分析

  • 地域別：市場（金額）
  • 地域別：市場実績と予測
  • 地域別：市場成長と市場シェアの比較

第11章 代謝性疾患治療薬市場のセグメンテーション

  • 市場実績と予測（金額）：タイプ別
  • 医薬品
  • 生物製剤
  • 市場実績と予測（金額）：薬剤タイプ別
  • 抗糖尿病薬
  • 抗甲状腺薬
  • 抗肥満
  • その他（副甲状腺機能亢進症、下垂体機能低下症、副腎機能低下症）
  • 市場実績と予測（金額）：流通チャネル別
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他
  • 市場実績と予測（金額）：投与経路別
  • 経口
  • 非経口
  • その他
  • 市場実績と予測（金額）：薬剤分類別
  • ブランド薬
  • ジェネリック薬
  • 市場実績と予測（金額）：購入方法別
  • 処方薬
  • 市販薬

第12章 代謝性疾患治療薬市場の指標

  • 世界市場規模、GDPの割合
  • 世界市場：一人当たりの平均支出

第13章 アジア太平洋の代謝性疾患治療薬市場

  • 市場概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府のイニシアチブ、規制、規制機関、主要な協会、徴収される税金、法人税の構造、投資、主要企業
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • 中国
    • オーストラリア
    • 香港
    • インド
    • インドネシア
    • 日本
    • マレーシア
    • ニュージーランド
    • フィリピン
    • シンガポール
    • 韓国
    • タイ
    • ベトナム

第14章 西欧の代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • オーストリア
    • ベルギー
    • デンマーク
    • フィンランド
    • フランス
    • ドイツ
    • アイルランド
    • イタリア
    • オランダ
    • ノルウェー
    • ポルトガル
    • スペイン
    • スウェーデン
    • スイス
    • 英国

第15章 東欧の代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • チェコ共和国
    • ポーランド
    • ルーマニア
    • ロシア

第16章 北米の代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • カナダ
    • メキシコ
    • 米国

第17章 南米の代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • アルゼンチン
    • ブラジル
    • チリ
    • コロンビア
    • ペルー
    • ベネズエラ

第18章 中東代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • サウジアラビア
    • イスラエル
    • トルコ
    • アラブ首長国連邦

第19章 アフリカ代謝性疾患治療薬市場

  • 市場概要
  • 国別：市場（金額）
  • 国別：市場実績と予測
  • 国別：市場成長と市場シェアの比較
  • 市場指標
  • タイプ別：市場（金額）
  • 国別：市場分析
    • エジプト
    • ナイジェリア
    • 南アフリカ

第20章 代謝性疾患治療薬市場の競合情勢

  • 競争市場概要
  • 市場シェア
  • 企業プロファイル
    • Novo Nordisk
    • Eli Lilly And Company
    • Novartis AG
    • Sanofi S.A
    • Merck & Co

第21章 代謝性疾患治療薬市場における主な合併と買収

第22章 市場の背景：医薬品市場

  • 医薬品市場の特徴
  • 世界の医薬品市場の実績と予測、成長：セグメント別（金額）
  • 世界の医薬品市場：地域別（金額）
  • 世界の医薬品市場の実績と予測：地域別
  • 世界の医薬品市場：タイプ別セグメンテーション（金額）

第23章 提言

  • 2026年の世界の代謝性疾患治療薬市場：成長国
  • 2026年の世界の代謝性疾患治療薬市場：成長セグメント
  • 2026年の世界の代謝性疾患治療薬市場：成長戦略

第24章 付録

第25章 著作権と免責事項

目次
Product Code: r679

“Metabolic Disorders Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Metabolic Disorders Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider metabolic disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By Drug Type: Anti Diabetics drugs; Anti-Thyroid Drugs; Antiobesity; Others (Hypopituitarism, Hypoadrenalism)
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • 6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Novo Nordisk; Eli Lilly And Company; Novartis AG; Sanofi S.A.; Merck & Co.
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Metabolic Disorders Drugs

9. Metabolic Disorders Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Metabolic Disorders Drugs Market Regional Analysis

  • 10.1. Global Metabolic Disorders Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

11. Metabolic Disorders Drugs Market Segmentation

  • 11.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Metabolic Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Anti Diabetics Drugs
  • Anti-Thyroid Drugs
  • Antiobesity
  • Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
  • 11.3. Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4. Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.6. Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Metabolic Disorders Drugs Market Metrics

  • 12.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Metabolic Disorders Drugs Market

  • 13.1. Asia-Pacific Metabolic Disorders Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • 13.6. Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis
    • 13.7.1. China Metabolic Disorders Drugs Market
      • 13.7.1.1. China Metabolic Disorders Drugs Market Overview
      • 13.7.1.2. China Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Metabolic Disorders Drugs Market
      • 13.7.2.1. Australia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Metabolic Disorders Drugs Market
      • 13.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Metabolic Disorders Drugs Market
      • 13.7.4.1. India Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Metabolic Disorders Drugs Market
      • 13.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Metabolic Disorders Drugs Market
      • 13.7.6.1. Japan Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Metabolic Disorders Drugs Market
      • 13.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Metabolic Disorders Drugs Market
      • 13.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Metabolic Disorders Drugs Market
      • 13.7.9.1. Philippines Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Metabolic Disorders Drugs Market
      • 13.7.10.1. Singapore Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Metabolic Disorders Drugs Market
      • 13.7.11.1. South Korea Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Metabolic Disorders Drugs Market
      • 13.7.12.1. Thailand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Metabolic Disorders Drugs Market
      • 13.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Metabolic Disorders Drugs Market

  • 14.1. Western Europe Metabolic Disorders Drugs Market Overview
  • 14.2. Western Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Metabolic Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
  • 14.6. Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis
    • 14.7.1. Austria Metabolic Disorders Drugs Market
      • 14.7.1.1. Austria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Metabolic Disorders Drugs Market
      • 14.7.2.1. Belgium Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Metabolic Disorders Drugs Market
      • 14.7.3.1. Denmark Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Metabolic Disorders Drugs Market
      • 14.7.4.1. Finland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Metabolic Disorders Drugs Market
      • 14.7.5.1. France Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Metabolic Disorders Drugs Market
      • 14.7.6.1. Germany Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Metabolic Disorders Drugs Market
      • 14.7.7.1. Ireland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Metabolic Disorders Drugs Market
      • 14.7.8.1. Italy Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Metabolic Disorders Drugs Market
      • 14.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Metabolic Disorders Drugs Market
      • 14.7.10.1. Norway Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Metabolic Disorders Drugs Market
      • 14.7.11.1. Portugal Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Metabolic Disorders Drugs Market
      • 14.7.12.1. Spain Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Metabolic Disorders Drugs Market
      • 14.7.13.1. Sweden Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Metabolic Disorders Drugs Market
      • 14.7.14.1. Switzerland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Metabolic Disorders Drugs Market
      • 14.7.15.1. UK Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Metabolic Disorders Drugs Market

  • 15.1. Eastern Europe Metabolic Disorders Drugs Market Overview
  • 15.2. Eastern Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • 15.6. Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Metabolic Disorders Drugs Market,
      • 15.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Metabolic Disorders Drugs Market
      • 15.7.2.1. Poland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Metabolic Disorders Drugs Market
      • 15.7.3.1. Romania Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Metabolic Disorders Drugs Market
      • 15.7.4.1. Russia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Metabolic Disorders Drugs Market

  • 16.1. North America Metabolic Disorders Drugs Market Overview
  • 16.2. North America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Metabolic Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, North America Countries
  • 16.6. North America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Metabolic Disorders Drugs Market: Country Analysis
    • 16.7.1. Canada Metabolic Disorders Drugs Market
      • 16.7.1.1. Canada Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Metabolic Disorders Drugs Market
      • 16.7.2.1. Mexico Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Metabolic Disorders Drugs Market
      • 16.7.3.1. USA Metabolic Disorders Drugs Market Overview
      • 16.7.3.2. USA Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Metabolic Disorders Drugs Market

  • 17.1. South America Metabolic Disorders Drugs Market Overview
  • 17.2. South America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Metabolic Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, South America Countries
  • 17.6. South America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Metabolic Disorders Drugs Market: Country Analysis
    • 17.7.1. Argentina Metabolic Disorders Drugs Market
      • 17.7.1.1. Argentina Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Metabolic Disorders Drugs Market
      • 17.7.1.1. Brazil Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Metabolic Disorders Drugs Market
      • 17.7.3.1. Chile Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Metabolic Disorders Drugs Market
      • 17.7.4.1. Colombia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Metabolic Disorders Drugs Market
      • 17.7.5.1. Peru Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Metabolic Disorders Drugs Market
      • 17.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Metabolic Disorders Drugs Market

  • 18.1. Middle East Metabolic Disorders Drugs Market Overview
  • 18.2. Middle East, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Metabolic Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Middle East Countries
  • 18.6. Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Metabolic Disorders Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Metabolic Disorders Drugs Market
      • 18.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Metabolic Disorders Drugs Market
      • 18.7.2.1. Israel Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Metabolic Disorders Drugs Market
      • 18.7.3.1. Turkey Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Metabolic Disorders Drugs Market
      • 18.7.4.1. UAE Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Metabolic Disorders Drugs Market

  • 19.1. Africa Metabolic Disorders Drugs Market Overview
  • 19.2. Africa, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Metabolic Disorders Drugs Market Metrics
    • 19.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Africa Countries
  • 19.6. Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Metabolic Disorders Drugs Market: Country Analysis
    • 19.7.1. Egypt Metabolic Disorders Drugs Market
      • 19.7.1.1. Egypt Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Metabolic Disorders Drugs Market
      • 19.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Metabolic Disorders Drugs Market
      • 19.7.3.1. South Africa Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Metabolic Disorders Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Novo Nordisk
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Eli Lilly And Company
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. Novartis AG
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Sanofi S.A
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. Merck & Co
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Metabolic Disorders Drugs Market In 2026- Growth Countries
  • 23.2. Global Metabolic Disorders Drugs Market In 2026- Growth Segments
  • 23.3. Global Metabolic Disorders Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer